| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 83881-37-2 | Acetamide,2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-; UCB-L 172 |  | C21H26CLN3O2 | 詳情 | 供應商 | |
| 112857-85-9 | 1H-Indole-4-carboxamide,N-[2-[2-[(1,1-dimethylethyl)amino]ethoxy]phenyl]-, hydrochloride (1:?); 1H-Indole-4-carboxamide,N-[2-[2-[(1,1-dimethylethyl)amino]ethoxy]phenyl]-, hydrochloride (9CI) |  | C21H26CLN3O2 | 詳情 | 供應商 | |
| 522-20-3 | 2-Propanol,1-[(6-chloro-2-methoxy-9-acridinyl)amino]-3-(diethylamino)-; 1-(6-Chloro-2-methoxy-9-acridylamino)-3-diethylamino-2-propanol; 5-(g-Diethylamino-b-hydroxypropyl)amino-3-methoxy-8-chloroacridine; Chlormetacrine |  | C21H26CLN3O2 | 詳情 | 供應商 | |
| 16711-38-9 | 4(1H)-Quinazolinone,1-[2-(diethylamino)acetyl]-2,3-dihydro-2-methyl-3-phenyl-, hydrochloride (1:1); 4(1H)-Quinazolinone,1-(N,N-diethylglycyl)-2,3-dihydro-2-methyl-3-phenyl-, monohydrochloride (8CI); 4(1H)-Quinazolinone, 1-[(diethylamino)acetyl]-2,3-dihydro-2-methyl-3-phenyl-,monohydrochloride (9CI) |  | C21H26CLN3O2 | 詳情 | 供應商 | |
| 93664-94-9 |  | C21H26CLN3O2 | 詳情 | 供應商 | ||
| 752154-64-6 | 反-5-氯-2-甲氧基-4-(甲基氨基)-N-[2-甲基-2-(苯基甲基)-3-吡咯烷基]苯甲酰胺 | transNemonapride; trans-5-Chloro-2-methoxy-4-(methylamino)-N-[2-methyl-1-(phenylmethyl)-3-pyrrolidinyl]-benzamide; transNemonapride |  | C21H26CLN3O2 | 詳情 | 供應商 |
| 75272-39-8 | 順-5-氯-2-甲氧基-4-(甲基氨基)-N-[2-甲基-2-(苯基甲基)-3-吡咯烷基]苯甲酰胺 | NEMONAPRIDE; CIS-5-CHLORO-2-METHOXY-4-(METHYLAMINO)-N-[2-METHYL-1-(PHENYLMETHYL)-3-PYRROLIDINYL]BENZAMIDE; REL-5-CHLORO-2-METHOXY-4-(METHYLAMINO)-N-[(2R,3R)-2-METHYL-2-(PHENNYLMETHYL)-3-PYRROLIDINYL]BENZAMIDE; NEMONAPRIDE; (+-)-cis-n-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylami; benzamide,5-chloro-2-methoxy-4-(methylamino)-n-(2-methyl-1-(phenylmethyl)-3-py; cis-(+-)-rrolidinyl); emonapride; inobenzamide |  | C21H26CLN3O2 | 詳情 | 供應商 |